Development
IperionX Limited
IPX
$38.29
-$0.33-0.85%
NASDAQ
12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 11.84M | 11.95M | 12.06M | 14.72M | 17.37M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 19.10M | 18.38M | 17.66M | 18.76M | 19.85M |
Operating Income | -19.10M | -18.38M | -17.66M | -18.76M | -19.85M |
Income Before Tax | -19.19M | -18.32M | -17.44M | -18.58M | -19.71M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -19.19 | -18.32 | -17.44 | -18.58 | -19.71 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -19.19M | -18.32M | -17.44M | -18.58M | -19.71M |
EBIT | -19.10M | -18.38M | -17.66M | -18.76M | -19.85M |
EBITDA | -18.96M | -18.28M | -17.59M | -18.72M | -19.83M |
EPS Basic | -0.10 | -0.10 | -0.11 | -0.12 | -0.14 |
Normalized Basic EPS | -0.06 | -0.06 | -0.07 | -0.08 | -0.09 |
EPS Diluted | -0.10 | -0.10 | -0.11 | -0.12 | -0.14 |
Normalized Diluted EPS | -0.06 | -0.06 | -0.07 | -0.08 | -0.09 |
Average Basic Shares Outstanding | 800.12M | 736.12M | 672.12M | 619.15M | 566.19M |
Average Diluted Shares Outstanding | 800.12M | 736.12M | 672.12M | 619.15M | 566.19M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |